Barclays PLC Cellebrite Di Ltd. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Barclays PLC holds 154,024 shares of CLBT stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,024
Previous 445,795
65.45%
Holding current value
$2.14 Million
Previous $9.82 Million
69.53%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CLBT
# of Institutions
213Shares Held
90.2MCall Options Held
177KPut Options Held
84.2K-
True Wind Capital Management, L.P.13.9MShares$193 Million93.81% of portfolio
-
Morgan Stanley New York, NY3.96MShares$55.1 Million0.01% of portfolio
-
Voss Capital, LLC Houston, TX3.84MShares$53.5 Million6.97% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.34MShares$46.5 Million0.67% of portfolio
-
Invesco Ltd. Atlanta, GA3.3MShares$45.8 Million0.01% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $2.64B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...